spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  MGI PHARMA 

 HSMN NewsFeed - 19 Jan 2021
GT Biopharma Appoints Two New Independent Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 21 Jun 2011
TESARO Announces $101 Million Series B Financing for Advancement and Expansion of Oncology Product Portfolio
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 24 May 2011
Cerecor, Incorporated Initiates Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Mar 2011
TESARO Enters into Exclusive License Agreement with Amgen to Acquire Rights to Anaplastic Lymphoma Kinase (ALK) Program
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 10 Jan 2011
Optimer Pharmaceuticals Announces Key Additions to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2010
Dr. Robert Petit Joins Advaxis as V.P. of Clinical Operations
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 18 Aug 2010
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Trân, Joan Manthis and William Pappafotopoulos to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2010
Lux Biosciences Names Dean Mitchell President and CEO
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 23 Jun 2010
Spectrum Pharmaceuticals Appoints James E. Shields as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2010
Tesaro, Inc. Secures $60 Million in Start-up Funding
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 5 Mar 2010
SurModics Announces Organizational and Leadership Changes
Devices Personnel
 HSMN NewsFeed - 17 Dec 2009
Dean Mitchell Appointed to Talecris Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2009
Access Pharmaceuticals Appoints Sales and Marketing Executive
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Sep 2009
New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 29 Jul 2009
Access Pharmaceuticals Announces New MuGard Commercial Strategy in North America
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Jul 2009
Abraxis BioScience Names Mary Lynne Hedley, Ph.D., Executive Vice President of Operations and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 Jul 2009
Abraxis BioScience Appoints Rick Rodgers Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 May 2009
Marty J. Duvall Joins Abraxis BioScience as Senior Vice President, Global Marketing and International Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Apr 2009
Abraxis BioScience Names Lonnie Moulder President and Chief Executive Officer; Soon-Shiong Remains Executive Chairman
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2009
DiaMedica Appoints Stephen J. Waters as Interim Chief Scientific Officer
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 14 Dec 2008
FDA Approves LUSEDRA(TM) (fospropofol disodium) Injection for Monitored Anesthesia Care (MAC) Sedation
Biopharmaceuticals FDA
 HSMN NewsFeed - 14 Aug 2008
Milestone Biosciences, LLC Further Strengthens Executive Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jul 2008
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 May 2008
Data Show Rufinamide, an Investigational Adjunctive Treatment for Lennox- Gastaut Syndrome, Reduced Drop Attacks by More Than 40%
Biopharmaceuticals Neurology
 HSMN NewsFeed - 5 May 2008
Eisai Corporation of North America Announces Appointment of Cynthia Schwalm as President, Eisai Inc.
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Apr 2008
Eisai Corporation of North America Announces Appointment of Vice President of U.S. Corporate Communications
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Apr 2008
European Regulatory Agency Grants Orphan Status to Morphotek(R)'s Farletuzumab and MORAb-009
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 2 Mar 2008
FDA Approves Aloxi(R) (Palonosetron HCL) Injection for Prevention of Postoperative Nausea and Vomiting
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Jan 2008
Eisai Completes Acquisition of MGI PHARMA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 18 Jan 2008
MGI PHARMA Announces Results from Study Involving the Dual Implantation of Gliadel(R) Wafer and Radioactive Seeds for Treatment of Recurrent Glioblastoma Multiforme
Biopharmaceuticals Oncology Neurosurgery
 HSMN NewsFeed - 17 Jan 2008
Eisai and MGI PHARMA Announce Early Termination of HSR Waiting Period for Eisai's Acquisition of MGI PHARMA
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 10 Dec 2007
Eisai to Acquire MGI PHARMA for $41 Per Share in an All Cash Transaction
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 29 Oct 2007
MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Capsules
Biopharmaceuticals
 HSMN NewsFeed - 22 Oct 2007
Aquavan(R) Phase 3 Bronchoscopy Data Presented At CHEST 2007
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2007
AkaRx and MGI PHARMA Announce Closing of Development and License Agreement
Biopharmaceuticals Licensing
 HSMN NewsFeed - 9 Oct 2007
Emergent BioSolutions Announces the Appointment of Denise Landry as Senior Vice President, Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2007
MGI PHARMA Announces Submission of Aquavan(R) New Drug Application
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Sep 2007
MGI PHARMA and HELSINN Announce Aloxi(R) sNDA Approval Allowing for Repeated Dosing for Cancer Patients Receiving Multiple Day Chemotherapy Regimens
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2007
MGI PHARMA Signs Agreement for Rights to Novel Treatment for Thrombocytopenia
Biopharmaceuticals Licensing
 HSMN NewsFeed - 11 Jul 2007
MGI PHARMA to Expand Presence in Lexington, MA
Biopharmaceuticals
 HSMN NewsFeed - 7 May 2007
MGI PHARMA and HELSINN Announce Submission of Supplemental New Drug Application for Aloxi(R) Injection in Post-Operative Nausea and Vomiting
Biopharmaceuticals
 HSMN NewsFeed - 16 Apr 2007
Data from Investigator-Sponsored Trial of Oncophage(R) Cancer Vaccine in Glioma Presented at American Association of Neurological Surgeons Annual Meeting
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Mar 2007
MGI PHARMA Announces Positive Results from a Pivotal Phase 3 Study of Aquavan(R) Injection in Patients Undergoing Bronchoscopy
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2007
NCCN Updates Myelodysplastic Syndromes (MDS) Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Feb 2007
MGI PHARMA and HELSINN HEALTHCARE SA Announce Patent Extension for Aloxi(R) Injection
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
NCCN Updates Antiemesis Guidelines
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Dec 2006
Medwave Names New Director, Adds Chief Financial Officer and Senior Vice President of Sales and Marketing
Devices Personnel
 HSMN NewsFeed - 14 Dec 2006
MGI PHARMA and HELSINN Announce Positive Phase 3 Results for Aloxi(R) (Palonosetron Hydrochloride) Injection for the Prevention of Post Operative Nausea & Vomiting
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2006
Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting
Biopharmaceuticals Neurosurgery Oncology
 HSMN NewsFeed - 24 Oct 2006
Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Oct 2006
MGI PHARMA Receives Approvable Letter for Saforis(TM) (Glutamine) Powder in UpTec(TM) for Oral Suspension
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Sep 2006
Actavis Launches Pilocarpine Tablets 7.5mg in the U.S.
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Jul 2006
MGI PHARMA Announces License Agreement with Cilag GmbH, a Johnson & Johnson Company, for Dacogen(TM) (decitabine) for Injection
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 22 Jun 2006
NeoPharm Announces Appointment of Vice-President of Regulatory Affairs and Quality Assurance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Alpharma Names Dean J. Mitchell President and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 May 2006
MGI PHARMA Announces Commercial Availability of Dacogen(TM) (Decitabine) for Injection
Biopharmaceuticals Oncology
 HSMN NewsFeed - 25 May 2006
Dr. Gerard T. Kennealey Joins MGI PHARMA as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 49

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 49 additional stories matching:
MGI PHARMA
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.